| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Actuate Therapeutics, Inc. Common Stock (ACTU) have been net buyers, picking up 140,844 shares worth roughly $50K on balance. In the past 30 days, 1 insider bought and 0 sold.
Daniel M Schmitt (President, CEO and Director) stands out among recent buyers, now holding an estimated $155K in ACTU.
Counted by filing, the last 12 months brought 1 open-market purchase by 1 insider worth about $50K and 1 sale by 1 insider worth about $1.6M. The 12 months before that brought 2 open-market purchases by 2 insiders worth about $1.0M and no sales.
The largest open-market purchase in the last two years was 71,428 shares by Aaron G.L. Fletcher (Director, 10% Owner) at an average $7.00 on June 27, 2025, about $500K. Twelve months later ACTU was down 72%.
The most recent purchase was by Daniel M Schmitt (President, CEO and Director) on October 28, 2026.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 904.8K | $316.7K | - | |
| CEO | 442.6K | $154.9K | +140.8K |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 28, 2026 | Daniel M Schmitt | President, CEO and Director | Buy | 140,844 | $0.36 | $49,999.62 | +46.7% | - | - | |
| Jan 5, 2026 | Todd S Thomson | Director, 10% Owner | Sell | 280,000 | $5.80 | $1,624,000.00 | -23.6% | -66.9% | - | |
| Jun 27, 2025 | Leslie W. Kreis45 | Director, 10% Owner | Buy | 71,428 | $7.00 | $499,996.00 | +57.1% | +11.6% | -71.8% | |
| Jun 27, 2025 | Aaron G.L. Fletcher47 | Director, 10% Owner | Buy | 71,428 | $7.00 | $499,996.00 | +57.1% | +11.6% | -71.8% | |
| Jun 27, 2025 | Bios Equity Cof, LP | Director, 10% Owner | Buy | 71,428 | $7.00 | $499,996.00 | +57.1% | +11.6% | -71.8% | |
| Aug 14, 2024 | Todd S Thomson | Director, 16.4% Owner | Sell | 18,750 | $8.00 | $150,000.00 | -1.6% | -1.4% | -10.2% | |
| Aug 14, 2024 | Bios Equity Cof, LP | Director, 10% Owner | Sell | 24,999 | $9.00 | $224,991.00 | -16.0% | -1.4% | -10.2% | |
| Aug 14, 2024 | Aaron G.L. Fletcher47 | Director, 10% Owner | Sell | 24,999 | $9.00 | $224,991.00 | -16.0% | -1.4% | -10.2% | |
| Aug 14, 2024 | Leslie W. Kreis45 | 10% Owner | Sell | 24,999 | $9.00 | $224,991.00 | -16.0% | -1.4% | -10.2% | |
| Aug 14, 2024 | Aaron G.L. Fletcher47 | Director, 10% Owner | Buy | 500,000 | $8.00 | $4,000,000.00 | -133.3% | -1.4% | -10.2% |